Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Marija Sullivan

4PUBLICATIONS

7CO-AUTHORS

Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (4)

Sort by Publication Date:

|Apr 28, 2026

Chemotherapy Declination Among Patients With Early-Stage Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer and High Oncotype DX Recurrence Scores.

|Feb 28, 2025

Use of adjuvant capecitabine in older patients with early-stage triple-negative breast cancer.

Marija Sullivan, Xiudong Lei, Meghan Karuturi

|Apr 05, 2024

Breast cancer (BC) and severe COVID-19 (C-19) outcomes: a matched analysis.

Marija Sullivan, Xiudong Lei, Sharon H Giordano

|Jan 03, 2024

Breast Cancer (BC) and Severe COVID-19 (C-19) Outcomes: A Matched Analysis.

Marija Sullivan, Xiudong Lei, Sharon H Giordano

Pageof 1

Frequent Collaborators

4 joint publications

Mariana Chavez-MacGregor

3 joint publications

Sharon H Giordano

2 joint publications

Xiudong Lei

1 joint publications

Meghan Karuturi

1 joint publications

Catalina Malinowski

1 joint publications

Inimfon Jackson

1 joint publications

Carlos H Barcenas

Frequent Collaborators

4 joint publications

Mariana Chavez-MacGregor

3 joint publications

Sharon H Giordano

2 joint publications

Xiudong Lei

1 joint publications

Meghan Karuturi

Top Related Videos

Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells

Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells

Published on : May 09, 2025

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice

Published on : Oct 05, 2017

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on : Sep 27, 2024

See more related videos

Top Related Videos

Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells

Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells

Published on : May 09, 2025

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice

Published on : Oct 05, 2017

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on : Sep 27, 2024

See more related videos